Obsidian Therapeutics (OBX) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 14 36 sessions, August 4, 2026 to September 23, 2026
- Largest daily move
- -32.4% close of August 13, 2026
Company Description
Obsidian Therapeutics (NASDAQ: OBX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $942.7M.
OBX has declined 23.3% over the past month. The last closing price was $15.26.
For FY2025, Obsidian Therapeutics reported revenue of $0 with net income of -$100.6M and diluted earnings per share of -$7.22.
This page collects what Stock Titan holds for OBX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Obsidian Therapeutics (OBX) closed at $15.26 on September 23, 2026. Over the past month, the price has lost 23.3%.
OBX Metrics & Rankings
Price returns through September 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Obsidian Therapeutics has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial, private placement. View all OBX news →
SEC Filings
Obsidian Therapeutics has filed 10 recent SEC filings, including 4 Form SCHEDULE 13G, 2 Form 4, 1 Form EFFECT, 1 Form S-1. The most recent filing was submitted on September 10, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all OBX SEC filings →
Financial Highlights
operating income reached -$105.7M, and net income was -$100.6M. Diluted earnings per share stood at -$7.22. The company generated -$90.4M in operating cash flow. With a current ratio of 5.31, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Obsidian Therapeutics (OBX) currently stands at 81.5 thousand shares, up 125.6% from the previous reporting period, representing 0.1% of the float. Since August 2026, short interest has increased by 125.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Obsidian Therapeutics (OBX) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
OBX Company Profile & Sector Positioning
Obsidian Therapeutics (OBX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.